Literature DB >> 11481329

Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells.

A D Everett1, T Stoops, C A McNamara.   

Abstract

We recently identified hepatoma-derived growth factor (HDGF) as a nuclear targeted vascular smooth muscle cell (VSM) mitogen that is expressed in developing vascular lesions. In the present study, VSM in culture express endogenous HDGF only in the nucleus and target a green fluorescent protein (GFP)-HDGF fusion to the nucleus. To define the features of the HDGF molecule that are essential for nuclear localization and mitogenic function, deletion and site-directed mutagenesis were performed. Deletion analysis identified the carboxyl-terminal half of HDGF to be responsible for nuclear targeting in VSM. Overexpression of tagged HDGF proteins with point mutations in the putative bipartite nuclear localization sequence in the carboxyl terminus demonstrated that single Lys --> Asn mutations randomized HDGF expression to both the nucleus and cytoplasm similar to the empty vector. Importantly, the Lys --> Asn mutation of all three lysines blocked nuclear entry. Point mutation of a p34(cdc2) kinase consensus motif within the nuclear localization sequence had no effect on nuclear targeting. Moreover, nuclear entry was essential for the HDGF mitogenic effect, as transfection with the triple Lys --> Asn mutant HA-HDGF significantly attenuated bromodeoxyuridine uptake when compared with transfection with wild type HA-HDGF. We conclude that HDGF contains a true bipartite nuclear localization sequence with all three lysines necessary for nuclear targeting. Nuclear targeting of HDGF is required for HDGF stimulation of DNA replication in VSM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481329     DOI: 10.1074/jbc.M105109200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.

Authors:  Dawei Li; Zhen Han; Jikai Liu; Xiang Zhang; Juchao Ren; Lei Yan; Hainan Liu; Zhonghua Xu
Journal:  Med Oncol       Date:  2013-09-03       Impact factor: 3.064

2.  Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.

Authors:  Sen Guo; Hong-da Liu; Yan-Feng Liu; Lei Liu; Qiang Sun; Xi-Jun Cui
Journal:  Tumour Biol       Date:  2014-09-28

3.  p53 and the PWWP domain containing effector proteins in chromatin damage repair.

Authors:  Jing Hu; Yanming Wang
Journal:  Cell Dev Biol       Date:  2013-05-10

4.  Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas.

Authors:  Shu-Shong Hsu; Chih-Hao Chen; Guei-Sheung Liu; Ming-Hong Tai; Jyh-Seng Wang; Jain-Ching Wu; Mei-Lang Kung; Elsa C Chan; Li-Feng Liu
Journal:  J Neurooncol       Date:  2011-10-26       Impact factor: 4.130

5.  The family of hepatoma-derived growth factor proteins: characterization of a new member HRP-4 and classification of its subfamilies.

Authors:  Frank Dietz; Sebastian Franken; Kenya Yoshida; Hideji Nakamura; Joachim Kappler; Volkmar Gieselmann
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

6.  Hepatoma-derived growth factor-related protein-3 interacts with microtubules and promotes neurite outgrowth in mouse cortical neurons.

Authors:  Heba M El-Tahir; Mekky M Abouzied; Rainer Gallitzendoerfer; Volkmar Gieselmann; Sebastian Franken
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

7.  Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K(2).

Authors:  Teruhisa Yamamoto; Hideji Nakamura; Weidong Liu; Ke Cao; Shohei Yoshikawa; Hirayuki Enomoto; Yoshinori Iwata; Noritoshi Koh; Masaki Saito; Hiroyasu Imanishi; Soji Shimomura; Hiroko Iijima; Toshikazu Hada; Shuhei Nishiguchi
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

8.  Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Authors:  Yanyan Zhou; Nanxiang Zhou; Weiyi Fang; Jirong Huo
Journal:  Diagn Pathol       Date:  2010-09-16       Impact factor: 2.644

9.  The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome.

Authors:  San-Zhong Li; Yong-Bo Zhao; Wei-Dong Cao; Yan Qu; Peng Luo; Hai-Ning Zhen; Xiao-Yan Chen; Zhi-Feng Yan; Zhou Fei
Journal:  Med Oncol       Date:  2013-06-15       Impact factor: 3.064

10.  Expression patterns and different subcellular localization of the growth factors HDGF (hepatoma-derived growth factor) and HRP-3 (HDGF-related protein-3) suggest functions in addition to their mitogenic activity.

Authors:  Mekky M Abouzied; Stephan L Baader; Frank Dietz; Joachim Kappler; Volkmar Gieselmann; Sebastian Franken
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.